Nasal spray flu vaccine approved for home use: Here’s what to know
The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca, was announced last week and can be used by adults aged 49 and under.
Novavax, COVID-19 vaccine
In August, the World Health Organization declared mpox a global public health emergency for the second time in two years.
(Reuters) - Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the ...
The Centers for Disease Control and Prevention (CDC) has issued a health advisory recommending that select travelers to ...
For those who are uninsured or under-insured, CDPH will have vaccine at its three CDPH Immunization Clinics. Walk-ins are ...
U.S. President Joe Biden announced on Tuesday the donation of 1 million mpox vaccine doses and at least $500 million to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback